Distribution and functions of catechol-O-methyltransferase proteins. Do recent findings change the picture?

International Review of Neurobiology

Volumn 95, Issue C, 2010, Pages 29-47

  Myöhänen, Timo T ^a   Männistö, Pekka T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Catechol O methyltransferase; COMT; COMT activity; COMT isoforms; COMT knock out mice; COMT mRNA; Function of COMT isoforms; Immunohistochemistry; MB COMT; S COMT; S COMT deficient mice

Indexed keywords

CATECHOL METHYLTRANSFERASE; ISOENZYME; MESSENGER RNA;

BOOK; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LOCALIZATION; GENE EXPRESSION; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE DISTRIBUTION; TISSUE LEVEL;

EID: 78649376594     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381326-8.00003-X     Document Type: Chapter

References (56)

1. Baldessarini R.J. Neuropharmacology of S-adenosyl-L-methionine. Am. J. Med. 1987, 5A:95-103.
2. Brisch R., Bernstein H.G., Krell D., Dobrowolny H., Bielau H., Steiner J., Gos T., Funke S., Stauch R., Knuppel S., Bogerts B. Dopamine-glutamate abnormalities in the frontal cortex associated with the catechol-O-methyltransferase (COMT) in schizophrenia. Brain Res. 2009, 7:166-175.
3. Broch O.J., Fonnum F. The regional and subcellular distribution of catechol-O-methyl transferase in the rat brain. J. Neurochem. 1972, 9:2049-2055.
4. Eisenhofer G., Keiser H., Friberg P., Mezey E., Huynh T.T., Hiremagalur B., Ellingson T., Duddempudi S., Eijsbouts A., Lenders J.W. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J. Clin. Endocrinol. Metab. 1998, 6:2175-2185.
5. Ellingson T., Duddempudi S., Greenberg B.D., Hooper D., Eisenhofer G. Determination of differential activities of soluble and membrane-bound catechol-O-methyltransferase in tissues and erythrocytes. J. Chromatogr. B. Biomed. Sci. Appl. 1999, 1-2:347-353.
6. Guldberg H.C., Marsden C.A. Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol. Rev. 1975, 2:135-206.
7. Head R.J., Irvine R.J., Barone S., Stitzel R.E., de la Lande I.S. Nonintracellular, cell-associated O-methylation of isoproterenol in the isolated rabbit thoracic aorta. J. Pharmacol. Exp. Ther. 1985, 1:184-189.
8. Helkamaa T., Männist P.T., Rauhala P., Cheng Z.J., Finckenberg P., Huotari M., Gogos J.A., Karayiorgou M., Mervaala E.M. Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice. J. Hypertens. 2003, 12:2365-2374.
9. Helkamaa T., Reenil I., Tuominen R.K., Soinila S., Väänänen A., Tilgmann C., Rauhala P. Increased catechol-O-methyltransferase activity and protein expression in OX-42-positive cells in the substantia nigra after lipopolysaccharide microinfusion. Neurochem. Int. 2007, 6-7:412-423.
10. Hill R.A., McInnes K.J., Gong E.C., Jones M.E., Simpson E.R., Boon W.C. Estrogen deficient male mice develop compulsive behavior. Biol. Psychiatry 2007, 3:359-366.
11. Hirata H., Hinoda Y., Okayama N., Suehiro Y., Kawamoto K., Kikuno N., Rabban J.T., Chen L.M., Dahiya R. COMT polymorphisms affecting protein expression are risk factors for endometrial cancer. Mol. Carcinog. 2008, 10:768-774.
12. Hong J., Shu-Leong H., Tao X., Lap-Ping Y. Distribution of catechol-O-methyltransferase expression in human central nervous system. NeuroReport 1998, 12:2861-2864.
13. Illi A., Sundberg S., Ojala-Karlsson P., Korhonen P., Scheinin M., Gordin A. The effect of entacapone on the disposition and hemodynamic effects of intravenous isoproterenol and epinephrine. Clin. Pharmacol. Ther. 1995, 2:221-227.
14. Inoue K., Creveling C.R. Immunocytochemical localization of catechol-O-methyltransferase in the oviduct and in macrophages in corpora lutea of rat. Cell Tissue Res. 1986, 3:623-628.
15. Inoue K., Tice L.W., Creveling C.R. Immunocytochemical localization of catechol-O-methyltransferase in the pregnant rat uterus. Endocrinology 1980, 6:1833-1840.
16. Jeffery D.R., Roth J.A. Characterization of membrane-bound and soluble catechol-O-methyltransferase from human frontal cortex. J. Neurochem. 1984, 3:826-832.
17. Jeffery D.R., Roth J.A. Kinetic reaction mechanism for magnesium binding to membrane-bound and soluble catechol O-methyltransferase. Biochemistry 1987, 10:2955-2958.
18. John K., Ragavan N., Pratt M.M., Singh P.B., Al-Buheissi S., Matanhelia S.S., Phillips D.H., Poirier M.C., Martin F.L. Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate. Prostate 2009, 5:505-519.
19. Kaakkola S., Gordin A., Männist P.T. General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase. Gen. Pharmacol. 1994, 5:813-824.
20. Käenmäki M., Tammimäki A., Garcia-Horsman J.A., Myöhänen T., Schendzielorz N., Karayiorgou M., Gogos J.A., Männist P.T. Importance of membrane-bound catechol-O-methyltransferase in L-DOPA metabolism: a pharmacokinetic study in two types of Comt gene modified mice. Br. J. Pharmacol. 2009, 8:1884-1894.
21. Kaplan G.P., Hartman B.K., Creveling C.R. Immunohistochemical demonstration of catechol-o-methyltransferase in mammalian brain. Brain Res. 1979, 2:241-250.
22. Kaplan G.P., Hartman B.K., Creveling C.R. Anti-catechol-O-methyltransferase: demonstration of specificity and immunological cross-reactivity with the enzyme from rat liver, kidney, brain, and choroid plexuses. Neurochem. Res. 1980, 8:869-877.
23. Kaplan G.P., Hartman B.K., Creveling C.R. Localization of catechol-O-methyltransferase in the leptomeninges, choroid plexus and ciliary epithelium: implications for the separation of central and peripheral catechols. Brain Res. 1981, 2:353-360.
24. Karhunen T., Tilgmann C., Ulmanen I., Julkunen I., Panula P. Distribution of catechol-O-methyltransferase enzyme in rat tissues. J. Histochem. Cytochem. 1994, 8:1079-1090.
25. Karhunen T., Tilgmann C., Ulmanen I., Panula P. Catechol-O-methyltransferase (COMT) in rat brain: immunoelectron microscopic study with an antiserum against rat recombinant COMT protein. Neurosci. Lett. 1995, 1:57-60.
26. Karhunen T., Tilgmann C., Ulmanen I., Panula P. Neuronal and non-neuronal catechol-O-methyltransferase in primary cultures of rat brain cells. Int. J. Dev. Neurosci. 1995, 8:825-834.
27. Karhunen T., Ulmanen I., Panula P. Catechol-O-methyltransferase in rat sensory ganglia and spinal cord. Neuroscience 1996, 1:267-276.
28. Kastner A., Anglade P., Bounaix C., Damier P., Javoy-Agid F., Bromet N., Agid Y., Hirsch E.C. Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system. Neuroscience 1994, 2:449-457.
29. Kinouchi S., Iga J., Ueno S., Yamauchi K., Numata S., Song H., Sumitani S., Shibuya-Tayoshi S., Haku M., Yasui T., Irahara M., Morita K., Rokutan K., Ohmori T. FKBP5, SERT and COMT mRNA expressions in the peripheral leukocytes during menstruation cycle in healthy reproductive females. Neurosci. Lett. 2008, 1:124-128.
30. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melen K., Julkunen I., Taskinen J. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995, 13:4202-4210.
31. Lundström K., Salminen M., Jalanko A., Savolainen R., Ulmanen I. Cloning and characterization of human placental catechol-O-methyltransferase cDNA. DNA Cell Biol. 1991, 3:181-189.
32. Lundström K., Tenhunen J., Tilgmann C., Karhunen T., Panula P., Ulmanen I. Cloning, expression and structure of catechol-O-methyltransferase. Biochim. Biophys. Acta 1995, 1:1-10.
33. Männist P.T., Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 1999, 4:593-628.
34. Männist P.T., Ulmanen I., Lundstrom K., Taskinen J., Tenhunen J., Tilgmann C., Kaakkola S. Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors. Prog. Drug Res. 1992, 39:291-350.
35. Matsumoto M., Weickert C.S., Akil M., Lipska B.K., Hyde T.M., Herman M.M., Kleinman J.E., Weinberger D.R. Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 2003, 1:127-137.
36. Myöhänen T.T., Schendzielorz N., Männist P.T. Distribution of catechol-O-methyl-transferase (COMT) proteins and enzymatic activities in wild-type and S-COMT deficient mice. J. Neurochem. 2010, 113:1632-1643.
37. Nackley A.G., Shabalina S.A., Tchivileva I.E., Satterfield K., Korchynskyi O., Makarov S.S., Maixner W., Diatchenko L. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006, 314:1930-1933.
38. Nomura T., Inoue K., Creveling C.R., Komatsu F., Ohta N., Chino T., Karasawa N., Nagatsu I. Immunocytochemical localization of aromatic L-amino acid decarboxylase and catechol-O-methyltransferase in blood vessel wall of the human dental pulp. Brain Res. 1996, 2:314-316.
39. Odlind C., Reenil I., Männist P.T., Ekblom J., Hansell P. The role of dopamine-metabolizing enzymes in the regulation of renal sodium excretion in the rat. Pflugers Arch. 2001, 4:505-510.
40. Odlind C., Reenil I., Männist P.T., Juvonen R., Uhlen S., Gogos J.A., Karayiorgou M., Hansell P. Reduced natriuretic response to acute sodium loading in COMT gene deleted mice. BMC Physiol. 2002, 2:14.
41. Overbye A., Seglen P.O. Phosphorylated and non-phosphorylated forms of catechol O-methyltransferase in rat liver, brain and other tissues. Biochem. J. 2009, 2:535-545.
42. Papaleo F., Crawley J.N., Song J., Lipska B.K., Pickel J., Weinberger D.R., Chen J. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J. Neurosci. 2008, 35:8709-8723.
43. Reenil I., Tuomainen P., Soinila S., Männist P.T. Increase of catechol-O-methyltransferase activity in rat brain microglia after intrastriatal infusion of fluorocitrate, a glial toxin. Neurosci. Lett. 1997, 3:155-158.
44. Rivett A.J., Eddy B.J., Roth J.A. Contribution of sulfate conjugation, deamination, and O-methylation to metabolism of dopamine and norepinephrine in human brain. J. Neurochem. 1982, 4:1009-1016.
45. Rivett A.J., Roth J.A. Kinetic studies on the O-methylation of dopamine by human brain membrane-bound catechol O-methyltransferase. Biochemistry 1982, 8:1740-1742.
46. Roth J.A. Membrane-bound catechol-O-methyltransferase: a re-evaluation of its role in the O-methylation of the catecholamine neurotransmitters. Rev. Physiol. Biochem. Pharmacol. 1992, 120:1-29.
47. Salminen M., Lundström K., Tilgmann C., Savolainen R., Kalkkinen N., Ulmanen I. Molecular cloning and characterization of rat liver catechol-O-methyltransferase. Gene 1990, 2:241-247.
48. Schultz E., Nissinen E. Inhibition of rat liver and duodenum soluble catechol-O-methyltransferase by a tight-binding inhibitor OR-462. Biochem. Pharmacol. 1989, 22:3953-3956.
49. Su A.I., Cooke M.P., Ching K.A., Hakak Y., Walker J.R., Wiltshire T., Orth A.P., Vega R.G., Sapinoso L.M., Moqrich A., Patapoutian A., Hampton G.M., Schultz P.G., Hogenesch J.B. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl. Acad. Sci. U.S.A. 2002, 7:4465-4470.
50. Sundberg S., Scheinin M., Ojala-Karlsson P., Akkila J., Gordin A. The effects of the COMT inhibitor nitecapone for one week on exercise haemodynamics and catecholamine disposition. Eur. J. Clin. Pharmacol. 1993, 3:287-290.
51. Sundberg S., Scheinin M., Ojala-Karlsson P., Kaakkola S., Akkila J., Gordin A. Exercise hemodynamics and catecholamine metabolism after catechol-O-methyltransferase inhibition with nitecapone. Clin. Pharmacol. Ther. 1990, 4:356-364.
52. Tenhunen J., Heikkilä P., Alanko A., Heinonen E., Akkila J., Ulmanen I. Soluble and membrane-bound catechol-O-methyltransferase in normal and malignant mammary gland. Cancer Lett. 1999, 1:75-84.
53. Trendelenburg U. The uptake and metabolism of 3H-catecholamines in rat cerebral cortex slices. Naunyn Schmiedebergs Arch. Pharmacol. 1989, 3:293-297.
54. Tsunoda M., Takezawa K., Masuda M., Imai K. Rat liver and kidney catechol-O-methyltransferase activity measured by high-performance liquid chromatography with fluorescence detection. Biomed. Chromatogr. 2002, 8:536-541.
55. Ulmanen I., Peranen J., Tenhunen J., Tilgmann C., Karhunen T., Panula P., Bernasconi L., Aubry J.P., Lundström K. Expression and intracellular localization of catechol O-methyltransferase in transfected mammalian cells. Eur. J. Biochem. 1997, 1-2:452-459.
56. Weinshilboum R.M., Raymond F.A. Calcium inhibition of rat liver catechol-O-methyltransferase. Biochem. Pharmacol. 1976, 5:573-579.